NASDAQ:IBBJ Defiance Nasdaq Junior Biotechnology ETF (IBBJ) Price, Holdings, & News → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free IBBJ Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$29.87▼$29.8750-Day Range$29.87▼$29.9452-Week Range$27.85▼$41.45VolumeN/AAverage Volume4,475 shsMarket Capitalization$7.47 millionAssets Under Management$2.54 millionDividend Yield1.00%Net Expense Ratio0.45% Stock AnalysisStock Analysis Get Defiance Nasdaq Junior Biotechnology ETF alerts: Email Address About Defiance Nasdaq Junior Biotechnology ETFRead More Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… IBBJ ETF News HeadlinesFebruary 21, 2024 | benzinga.comNautilus Biotechnology Stock (NASDAQ:NAUT) Insider TradesDecember 21, 2023 | msn.comiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.1239April 25, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… July 24, 2023 | money.usnews.comBlackRock Institutional Trust Company N.A. - iShares Biotechnology ETFMarch 21, 2023 | investing.comiShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC)January 14, 2023 | thestreet.comFour ETF Plays for BiotechJanuary 3, 2023 | msn.com1 Large-Cap Biotech Stock to Buy for 2023 and BeyondSee More Headlines Receive IBBJ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Defiance Nasdaq Junior Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerDefiance ETFs Fund NameDefiance Nasdaq Junior Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBBJ Inception Date8/4/2020 Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Junior Biotechnology Index CategoryHealth Care FocusSector Development LevelBlended Develoment RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$2.54 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorDefiance ETFs, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerN/A Miscellaneous Outstanding Shares250,000BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Defiance Nasdaq Junior Biotechnology ETF ExpensesTypeIBBJEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.54%0.48%0.51%Other Expenses0.00%0.54%0.34%0.58%Total Expense0.45%0.70%0.58%0.70%Fee Waiver0.00%-0.54%-0.22%-0.57%Net Expense0.45%0.60%0.54%0.58% Defiance Nasdaq Junior Biotechnology ETF (IBBJ) ExposureIBBJ Sector ExposureIBBJ Industry ExposureFull Holdings Details IBBJ ETF - Frequently Asked Questions What does IBBJ invest in? Defiance Nasdaq Junior Biotechnology ETF is a equity fund issued by Defiance ETFs. IBBJ focuses on sector investments and follows the Nasdaq Junior Biotechnology Index. The fund's investments total to approximately $2.54 million assets under management. What is the management fee for Defiance Nasdaq Junior Biotechnology ETF? Defiance Nasdaq Junior Biotechnology ETF's management fee is 0.45% and has no other recorded expenses or fee waivers. The net expense ratio for IBBJ is 0.45%. This page (NASDAQ:IBBJ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defiance Nasdaq Junior Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
